Gain Access to exclusive preclinical content.
Complete the form below to gain access to mattis aliquet nunc aliquam tempor. We’ll assign a user name and password, then send you a link. Thanks!

Get Access Register

EXCLUSIVE PRECLINICAL CONTENT.
You must log in to access content on this page. Or click here to request access.
PEOPLE
Advancing fluorescent technology to help improve patient care.

From our leadership team, board of directors, to our advisors and employees, everyone at MediBeacon is focused on creating technology that has the potential to make a measurable difference in global health. The Company is focused on advancing the use of fluorescent tracer agents and transdermal detection technology to provide vital and actionable measurement of organ function.

Management
Advisors
Board of Directors
Steven J. Hanley, MBA
Chief Executive Officer and Co-Founder
Richard B. Dorshow, PhD
Chief Scientific Officer, President, and Co-Founder
Terence H. Stern, MBA
Vice President, Business Development
James M. Harr
Vice President, Research and Development
Stuart L Goldstein, MD, FAAP, FASN, FNKF
Professor of Medicine Cincinnati Children’s Medical Center – MediBeacon Director of Clinical Development
Joseph V. Bonventre, MD, PhD, FASN
Professor of Medicine Harvard Medical School
Stuart L Goldstein, MD, FAAP, FASN, FNKF
Professor of Medicine Cincinnati Children’s Medical Center – MediBeacon Director of Clinical Development
Steven B. Miller, MD
Chief Clinical Officer, Cigna Corporation
Phillip I. Tarr, MD
Professor of Pediatrics and Molecular Microbiology Washington University School of Medicine
Steven J. Hanley, MBA
Chief Executive Officer and Co-Founder
Richard B. Dorshow, PhD
Chief Scientific Officer, President, and Co-Founder
Steven B. Miller, MD
Chief Clinical Officer, Cigna Corporation